Published in J Biol Chem on April 03, 2012
Human isoprenoid synthase enzymes as therapeutic targets. Front Chem (2014) 0.86
Graphiumins, new thiodiketopiperazines from the marine-derived fungus Graphium sp. OPMF00224. J Antibiot (Tokyo) (2015) 0.80
Crystallization and preliminary X-ray diffraction analysis of YisP protein from Bacillus subtilis subsp. subtilis strain 168. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.78
A squalene synthase-like enzyme initiates production of tetraterpenoid hydrocarbons in Botryococcus braunii Race L. Nat Commun (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins (2003) 32.38
Natural products as sources of new drugs over the last 25 years. J Nat Prod (2007) 13.98
Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol (2003) 9.69
Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med (2005) 3.36
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science (2008) 2.96
Functional microdomains in bacterial membranes. Genes Dev (2010) 2.50
Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun (2006) 2.13
Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis. J Biol Chem (2000) 2.08
Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep (2009) 1.97
Cholesterol biosynthesis modulation regulates dengue viral replication. Virology (2009) 1.64
The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. J Med Chem (1996) 1.62
Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs. Interdiscip Perspect Infect Dis (2009) 1.32
Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase. Annu Rev Microbiol (1995) 1.27
Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem (2004) 1.19
Mechanism of action and inhibition of dehydrosqualene synthase. Proc Natl Acad Sci U S A (2010) 1.11
Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. J Med Chem (2009) 0.99
Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway. Clin Genet (2008) 0.98
Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential. Drugs (2007) 0.98
Structure and regulation of mammalian squalene synthase. Biochim Biophys Acta (2000) 0.94
Truncation of human squalene synthase yields active, crystallizable protein. Arch Biochem Biophys (1998) 0.93
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results. J Med Chem (2009) 0.91
Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42). Neuropharmacology (2007) 0.89
A general access to zaragozic acids: total synthesis and structure elucidation of zaragozic acid D and formal syntheses of zaragozic acids A and C. Chemistry (2011) 0.88
Advancing therapy for hypercholesterolemia. Expert Opin Pharmacother (2010) 0.86
Viridiofungins, novel inhibitors of sphingolipid synthesis. J Antibiot (Tokyo) (1997) 0.86
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives. J Med Chem (1994) 0.83
Squalene synthase inhibitors: their potential as hypocholesterolaemic agents. Prog Med Chem (1996) 0.83
Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase. J Nat Prod (1993) 0.81
The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors. J Med Chem (1996) 0.77
Novel approach to the zaragozic acids. Enantioselective total synthesis of 6,7-dideoxysqualestatin H5. J Org Chem (2002) 0.77
The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues. J Med Chem (1994) 0.77
Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition. J Med Chem (1994) 0.77
Identification of novel mammalian squalene synthase inhibitors using a three-dimensional pharmacophore. Bioorg Med Chem (2002) 0.77
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science (2008) 2.96
Structure, mechanism and function of prenyltransferases. Eur J Biochem (2002) 2.63
Right or left turn? RecA family protein filaments promote homologous recombination through clockwise axial rotation. Bioessays (2008) 2.05
Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A (2007) 2.00
High-throughput screening of soluble recombinant proteins. Protein Sci (2002) 1.90
The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris. J Mol Biol (2009) 1.78
Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. J Am Chem Soc (2009) 1.75
Genomic and proteomic analysis of thirty-nine structural proteins of shrimp white spot syndrome virus. J Virol (2004) 1.65
Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis. J Biol Chem (2005) 1.62
Precise mapping of increased sialylation pattern and the expression of acute phase proteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics. J Proteome Res (2008) 1.51
Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling. Crit Care Med (2007) 1.51
Phasevarions mediate random switching of gene expression in pathogenic Neisseria. PLoS Pathog (2009) 1.48
Identification of the nucleocapsid, tegument, and envelope proteins of the shrimp white spot syndrome virus virion. J Virol (2006) 1.42
Cysteine S-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation. J Biol Chem (2008) 1.40
The refined crystal structure of an eel pout type III antifreeze protein RD1 at 0.62-A resolution reveals structural microheterogeneity of protein and solvation. Biophys J (2003) 1.36
Structural and functional analysis of three β-glucosidases from bacterium Clostridium cellulovorans, fungus Trichoderma reesei and termite Neotermes koshunensis. J Struct Biol (2010) 1.33
Discovery of virulence factors of pathogenic bacteria. Curr Opin Chem Biol (2008) 1.31
Heterodimeric complexes of Hop2 and Mnd1 function with Dmc1 to promote meiotic homolog juxtaposition and strand assimilation. Proc Natl Acad Sci U S A (2004) 1.30
Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem (2005) 1.27
Crystal structure of yeast cytosine deaminase. Insights into enzyme mechanism and evolution. J Biol Chem (2003) 1.26
Dual binding sites for translocation catalysis by Escherichia coli glutathionylspermidine synthetase. EMBO J (2006) 1.24
Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem (2009) 1.23
Cloning, purification, crystallization and preliminary X-ray crystallographic analysis of XC847, a 3'-5' oligoribonuclease from Xanthomonas campestris. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 1.19
Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons. J Bacteriol (2005) 1.19
Crystal structure of type-III geranylgeranyl pyrophosphate synthase from Saccharomyces cerevisiae and the mechanism of product chain length determination. J Biol Chem (2006) 1.19
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation. J Med Chem (2008) 1.18
White spot syndrome virus annexes a shrimp STAT to enhance expression of the immediate-early gene ie1. J Virol (2006) 1.17
White spot syndrome virus protein ICP11: A histone-binding DNA mimic that disrupts nucleosome assembly. Proc Natl Acad Sci U S A (2008) 1.16
Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase. Protein Sci (2003) 1.14
Protein expression profiling of the shrimp cellular response to white spot syndrome virus infection. Dev Comp Immunol (2006) 1.14
Catalytic mechanism revealed by the crystal structure of undecaprenyl pyrophosphate synthase in complex with sulfate, magnesium, and triton. J Biol Chem (2003) 1.13
Self-cleavage of fusion protein in vivo using TEV protease to yield native protein. Protein Sci (2005) 1.13
Crystal structure of the left-handed archaeal RadA helical filament: identification of a functional motif for controlling quaternary structures and enzymatic functions of RecA family proteins. Nucleic Acids Res (2007) 1.12
Mechanism of action and inhibition of dehydrosqualene synthase. Proc Natl Acad Sci U S A (2010) 1.11
Structure and mechanism of Helicobacter pylori fucosyltransferase. A basis for lipopolysaccharide variation and inhibitor design. J Biol Chem (2007) 1.10
Substrate binding mode and reaction mechanism of undecaprenyl pyrophosphate synthase deduced from crystallographic studies. Protein Sci (2004) 1.09
Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation. J Biol Chem (2007) 1.08
Crystal structure of octaprenyl pyrophosphate synthase from hyperthermophilic Thermotoga maritima and mechanism of product chain length determination. J Biol Chem (2003) 1.08
Unusual DNA duplex and hairpin motifs. Nucleic Acids Res (2003) 1.08
Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion. Nucleic Acids Res (2004) 1.08
A modified protein precipitation procedure for efficient removal of albumin from serum. Electrophoresis (2005) 1.07
The many blades of the β-propeller proteins: conserved but versatile. Trends Biochem Sci (2011) 1.07
Crystal structures of the human SUMO-2 protein at 1.6 A and 1.2 A resolution: implication on the functional differences of SUMO proteins. Eur J Biochem (2004) 1.05
Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. J Biol Chem (2012) 1.04
Maturation processing and characterization of streptopain. J Biol Chem (2003) 1.04
Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. J Biomed Sci (2004) 1.02
Crystal structure of infectious bursal disease virus VP2 subviral particle at 2.6A resolution: implications in virion assembly and immunogenicity. J Struct Biol (2006) 1.01
Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides. PLoS One (2013) 1.00
Crystal structure of D-aminoacylase from Alcaligenes faecalis DA1. A novel subset of amidohydrolases and insights into the enzyme mechanism. J Biol Chem (2002) 1.00
Insights into the alkyl peroxide reduction pathway of Xanthomonas campestris bacterioferritin comigratory protein from the trapped intermediate-ligand complex structures. J Mol Biol (2009) 0.99
The structure and inhibition of a GGDEF diguanylate cyclase complexed with (c-di-GMP)(2) at the active site. Acta Crystallogr D Biol Crystallogr (2011) 0.99
Crystal structure and substrate-binding mode of cellulase 12A from Thermotoga maritima. Proteins (2011) 0.99
TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling. Shock (2008) 0.99
Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases. J Biomed Biotechnol (2008) 0.99
Crystal structure of the hyperthermophilic archaeal DNA-binding protein Sso10b2 at a resolution of 1.85 Angstroms. J Bacteriol (2003) 0.98
Structures of Selenomonas ruminantium phytase in complex with persulfated phytate: DSP phytase fold and mechanism for sequential substrate hydrolysis. Structure (2004) 0.98
Protein S-thiolation by Glutathionylspermidine (Gsp): the role of Escherichia coli Gsp synthetASE/amidase in redox regulation. J Biol Chem (2010) 0.97
Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines. Proteomics (2003) 0.96
Structure of a heterotetrameric geranyl pyrophosphate synthase from mint (Mentha piperita) reveals intersubunit regulation. Plant Cell (2010) 0.96
Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis. Nucleic Acids Res (2008) 0.96
Structural study of TcaR and its complexes with multiple antibiotics from Staphylococcus epidermidis. Proc Natl Acad Sci U S A (2010) 0.96
Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases. Nucleic Acids Res (2002) 0.96
Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation. Proc Natl Acad Sci U S A (2005) 0.94
Crystal structure of the C-terminal domain of a flagellar hook-capping protein from Xanthomonas campestris. J Mol Biol (2008) 0.94
Antibacterial drug leads: DNA and enzyme multitargeting. J Med Chem (2015) 0.94
Self-polymerization of archaeal RadA protein into long and fine helical filaments. Biochem Biophys Res Commun (2004) 0.92
Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases. Proteins (2008) 0.92